当前位置: 首页 > 期刊 > 《中国现代医生》 > 2021年第23期
编号:669561
芪归益肾汤治疗应用PD-1/PD-L1抑制剂后肿瘤患者急性肾损伤的临床研究
http://www.100md.com 2021年11月14日 中国现代医生 2021年第23期
     吴玲艳 米虽才 许正锦 贺斐 苏雨田 周燕妮

    [关键词] 芪归益肾汤;肿瘤免疫治疗;急性肾损伤;ICPIs相关肾毒性

    [中图分类号] R692.5? ? ? ? ? [文献标识码] B? ? ? ? ? [文章编号] 1673-9701(2021)23-0124-05

    Clinical study of Qigui Yishen Decoction in treating acute kidney injury of tumor patients after application of PD-1/PD-L1 inhibitor

    WU Lingyan1? ?MI Suicai2? ?XU Zhengjin1? ?HE Fei1? ?SU Yutian1? ?ZHOU Yanni1

    1.Department of Nephrology, Xiamen Hospital of Traditional Chinese Medicine, Xiamen? ?361009, China; 2.Department of Oncology, Xiamen Hospital of Traditional Chinese Medicine, Xiamen? ?361009, China

    [Abstract] Objective To explore the curative effect of Qigui Yishen Decoction in the treatment of patients with acute kidney injury caused by malignant tumors with PD-1/PD-L1 immune checkpoint inhibitors. Methods A total of 48 tumor patients with acute kidney injury who were treated with ICIs in the oncology department of our hospital from March 2019 to December 2020 were enrolled. The renal function indexes (BUN ......

您现在查看是摘要页,全文长 10910 字符